Search Results - "Walia, Yashna"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    S-Nitrosylation: An Emerging Paradigm of Redox Signaling by Fernando, Veani, Zheng, Xunzhen, Walia, Yashna, Sharma, Vandana, Letson, Joshua, Furuta, Saori

    Published in Antioxidants (17-09-2019)
    “…Nitric oxide (NO) is a highly reactive molecule, generated through metabolism of L-arginine by NO synthase (NOS). Abnormal NO levels in mammalian cells are…”
    Get full text
    Journal Article
  2. 2

    S-Nitrosylation in Tumor Microenvironment by Sharma, Vandana, Fernando, Veani, Letson, Joshua, Walia, Yashna, Zheng, Xunzhen, Fackelman, Daniel, Furuta, Saori

    “…S-nitrosylation is a selective and reversible post-translational modification of protein thiols by nitric oxide (NO), which is a bioactive signaling molecule,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ by Ren, Gang, Zheng, Xunzhen, Bommarito, Matthew, Metzger, Samantha, Walia, Yashna, Letson, Joshua, Schroering, Allen, Kalinoski, Andrea, Weaver, David, Figy, Christopher, Yeung, Kam, Furuta, Saori

    Published in Scientific reports (30-04-2019)
    “…One third of newly diagnosed breast cancers in the US are early-stage lesions. The etiological understanding and treatment of these lesions have become major…”
    Get full text
    Journal Article
  5. 5

    Reconstituting Breast Tissue with Organotypic Three-dimensional Co-culture of Epithelial and Stromal Cells in Discontinuous Extracellular Matrices by Ren, Gang, Sharma, Vandana, Letson, Joshua, Walia, Yashna, Fernando, Veani, Furuta, Saori

    Published in Bio-protocol (05-10-2019)
    “…Co-culture systems utilizing reconstituted or synthetic extracellular matrix (ECM) and micropatterning techniques have enabled the reconstruction of surface…”
    Get full text
    Journal Article
  6. 6

    Differential Toxicity of mDia Formin-Directed Functional Agonists and Antagonists in Developing Zebrafish by LeCorgne, Hunter, Tudosie, Andrew M, Lavik, Kari, Su, Robin, Becker, Kathryn N, Moore, Sara, Walia, Yashna, Wisner, Alexander, Koehler, Daniel, Alberts, Arthur S, Williams, Frederick E, Eisenmann, Kathryn M

    Published in Frontiers in pharmacology (10-04-2018)
    “…The mammalian Diaphanous-related (mDia) formins are cytoskeletal regulators that assemble and, in some cases, bundle filamentous actin (F-actin), as well as…”
    Get full text
    Journal Article
  7. 7

    The landscape of alterations affecting epigenetic regulators in T‐cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities by Walia, Yashna, Bock, Charles E., Huang, Yizhou

    Published in International journal of cancer (01-05-2024)
    “…T‐cell acute lymphoblastic leukemia (T‐ALL) is an aggressive malignancy accounting for 10%–15% of pediatric and 20%–25% of adult ALL cases. Epigenetic…”
    Get full text
    Journal Article
  8. 8

    Correction of arginine metabolism with sepiapterin—the precursor of nitric oxide synthase cofactor BH4—induces immunostimulatory-shift of breast cancer by Zheng, Xunzhen, Fernando, Veani, Sharma, Vandana, Walia, Yashna, Letson, Joshua, Furuta, Saori

    Published in Biochemical pharmacology (01-06-2020)
    “…[Display omitted] Immunotherapy is a first-line treatment for many tumor types. However, most breast tumors are immuno-suppressive and only modestly respond to…”
    Get full text
    Journal Article
  9. 9

    Effect of S-Nitrosylation on HER2 Protein Expression and Activity by Walia, Yashna

    Published 01-01-2021
    “…Among women in the US, breast cancer is the second leading cause of cancer related death, only preceded by lung cancer. This study primarily focuses on HER2,…”
    Get full text
    Dissertation
  10. 10

    Correction of arginine metabolism with sepiapterin-the precursor of nitric oxide synthase cofactor BH 4 -induces immunostimulatory-shift of breast cancer by Zheng, Xunzhen, Fernando, Veani, Sharma, Vandana, Walia, Yashna, Letson, Joshua, Furuta, Saori

    Published in Biochemical pharmacology (01-06-2020)
    “…Immunotherapy is a first-line treatment for many tumor types. However, most breast tumors are immuno-suppressive and only modestly respond to immunotherapy. We…”
    Get full text
    Journal Article